Glycopyrronium Bromide Powder for Inhalation

Novartis Pharma Schweiz AG🇨🇳 National Medical Products Administration

Approval Id: 8BYs5djT39V
Approval Number: 国药准字HJ20180002
Generic Name: 格隆溴铵吸入粉雾剂
Generic Name En: Glycopyrronium Bromide Powder for Inhalation
Trade Name: 希润
Drug Type: 化学药品
Dosage Form: 吸入粉雾剂
Strength: 50μg（以C₁₉H₂₈NO₃计）
Reg Date: 2021-07-01
Expired Date: 2026-06-30
Company Name: Novartis Pharma Schweiz AG
Company Address: 6343 Risch, Switzerland
Production Company Name: siegfried barbera, s.l
Production Company Address: Ronda Santa Maria 158, 08210 Barbera del Valles, Barcelona, Spain
Company Detail Path: /organization/novartis-pharma-schweiz-ag

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Jul 1, 2021

Approval ID

8BYs5djT39V

Type

化学药品